News Formal

The forgotten pharma stocks left in the dust by Eli-Lilly could be primed for a comeback

  • 📰 CNBC
  • ⏱ Reading Time:
  • 20 sec. here
  • 8 min. at publisher
  • 📊 Quality Score:
  • News: 32%
  • Publisher: 72%

Pfizer Inc ニュース

Johnson & Johnson,Bristol-Myers Squibb Co,Eli Lilly And Co

Katie Stockton breaks down the charts in Bristol-Myers, J&J and Pfizer.

Eli Lilly and Co. has gained roughly 63% this year, outperforming the S & P 500 Pharmaceuticals index by over 40%. The strong outperformance from LLY has been associated with strong underperformance by other high-profile stocks within the industry group. They may be ready to catch up, according to the charts. Bristol-Myers Squibb Co. , Johnson & Johnson , and Pfizer Inc. are three examples of pharmaceutical stocks that have been out of favor. All three have cyclical downtrends in place.

All opinions expressed by the CNBC Pro contributors are solely their opinions and do not reflect the opinions of CNBC, NBC UNIVERSAL, their parent company or affiliates, and may have been previously disseminated by them on television, radio, internet or another medium. THE ABOVE CONTENT IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY .

Click here for the full disclaimer.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 12. in JP
 

コメントありがとうございます。コメントは審査後に公開されます。

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

10 things to watch in the stock market Friday including more bullishness on Eli LillyWall Street is lower Friday morning after a strong session Thursday extended the market comeback.
ソース: CNBC - 🏆 12. / 72 続きを読む »